InvestorsHub Logo
Followers 261
Posts 13812
Boards Moderated 0
Alias Born 04/12/2007

Re: Followmylead post# 230

Tuesday, 06/20/2017 12:41:50 PM

Tuesday, June 20, 2017 12:41:50 PM

Post# of 1237
Same here, but won´t sell a single shares in the high 0,70´s. Looks like FDA approval for an unique lactose intolerance treatment is possible this year...

RP-G28 has the potential to become the first FDA-approved drug for the treatment of lactose intolerance, a debilitating disease that affects over one billion people worldwide.



The Phase 2b/3 program is underway. Results expected in 2017.



http://www.ritterpharmaceuticals.com/product-platform/rpg28